Medtronic PLC has unveiled a significant new partnership with Cornerstone Robotics Ltd., highlighted by a substantial investment of $700 million. This collaboration allows Medtronic to distribute Cornerstone’s Sentire surgical system in specific international markets where it has received approval, amplifying the reach of advanced surgical technologies.
Expanding Robotic Surgery Access
The integration of Cornerstone’s Sentire system with Medtronic’s existing Hugo robotic-assisted surgery (RAS) platform is set to enhance the accessibility and flexibility of robotic-assisted surgical options for surgeons around the globe. Medtronic’s Minneapolis headquarters is poised to leverage this partnership to strengthen its position in the growing field of minimally invasive surgery.
Matt Anderson, Medtronic’s Senior Vice President and President of Surgical, emphasized the company’s commitment to innovation in surgical practices. He stated, “Our strategy is focused on driving the next generation of minimally invasive surgery, one of our biggest growth opportunities.” This investment underscores the diverse needs of surgeons, healthcare systems, and markets, prompting Medtronic to diversify its robotic platforms and digital solutions.
The Sentire System’s Unique Features
Cornerstone Robotics has designed the Sentire system with a focus on versatility and user-friendliness. This system boasts a dual-console capability, allowing it to adapt to various surgical preferences and requirements. It has successfully completed clinical trials across multiple specialties and has achieved market approval in regions including China, the European Union, and Singapore.
In May 2026, Sentire received the CE Mark, enabling its use in a variety of minimally invasive procedures encompassing general, gynecologic, thoracic, and urologic surgeries. Samuel Au, the founder and CEO of Cornerstone Robotics, expressed confidence that this partnership will yield significant benefits for both physicians and patients as they work to enhance access to advanced surgical technologies.
Building on Hugo’s Momentum
The Medtronic-Hugo RAS platform has already made significant strides, being utilized by surgeons in over 35 countries across six continents, including the U.S., where it received FDA clearance within the past year. The growth rate of procedures using Hugo is reported to be more than double that of the overall robotic surgery market, with Medtronic projecting that total procedures will surpass 50,000 globally by the close of its fiscal year.
This partnership not only enhances the offerings available to surgeons but also aligns with Medtronic’s ongoing commitment to innovate its surgical technologies. The company has also recently invested $80 million into Pi-Cardia, a firm specializing in complex transcatheter aortic valve replacement (TAVR) technology, further expanding its presence in the surgical tech landscape.
Future Enhancements and Innovations
Medtronic remains dedicated to evolving the capabilities of the Hugo platform. Planned advancements include software upgrades, real-time AI integration across its digital ecosystem, and expanded instrumentation options. The Hugo system, designed as a modular, multi-quadrant platform, is tailored for a wide array of soft-tissue surgical procedures, combining innovative wristed instruments with 3D visualization and Touch Surgery capabilities.
Earlier this year, Medtronic provided a glimpse into its AI-powered compute platform, known as the Touch Surgery Aide, which enhances the functionality of its surgical ecosystem. This robust framework aims to streamline surgical workflows and optimize patient outcomes.
Conclusion
Medtronic’s $700 million investment in Cornerstone Robotics marks a pivotal expansion in the realm of robotic-assisted surgery. By uniting the capabilities of the Hugo and Sentire systems, Medtronic is poised to redefine surgical practices, providing enhanced access and innovative solutions to healthcare providers. This strategic move not only reinforces Medtronic’s leadership in the surgical technology market but also sets the stage for continued advancements that benefit patients and clinicians alike.
- Medtronic invests $700 million in Cornerstone Robotics.
- Sentire system approved for use in multiple countries.
- Hugo platform sees rapid growth in surgical procedures.
- Partnership aims to enhance access to robotic surgery.
- Medtronic focuses on innovation and technology integration in surgery.
Read more → www.therobotreport.com